Clinical Significance of B Cell-Activating Factor in Autoimmune Pancreatitis
PANCREAS (2011)
Journal
PANCREAS
Volume 40, Issue 6, Pages 840-845Publisher
LIPPINCOTT WILLIAMS & WILKINS
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Autoimmune Pancreatitis: From Pathogenesis to Treatment
Enrico Celestino Nista, Sara Sofia De Lucia, Vittoria Manilla, Tommaso Schepis, Antonio Pellegrino, Veronica Ojetti, Giulia Pignataro, Lorenzo Zileri dal Verme, Francesco Franceschi, Antonio Gasbarrini, Marcello Candelli
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, Camiel M. J. Marijnissen, Rob A. de Man, Annemiek A. van der Eijk, Adriaan J. van der Meer, Leendert A. Trouw, Bart van Hoek
JHEP REPORTS (2022)
Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach
Guillaume Le Cosquer, Charlotte Maulat, Barbara Bournet, Pierre Cordelier, Etienne Buscail, Louis Buscail
CANCERS (2023)
B cell-activating factors in autoimmune pulmonary alveolar proteinosis
Masaki Hirose, Toru Arai, Chikatoshi Sugimoto, Takayuki Takimoto, Reiko Sugawara, Shojiro Minomo, Sayoko Shintani, Naoko Takeuchi, Kanako Katayama, Yasushi Inoue, Tomoko Kagawa, Takahiko Kasai, Masanori Akira, Yoshikazu Inoue
ORPHANET JOURNAL OF RARE DISEASES (2021)
Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: A review
Yuhong Liu, Zhihua Tu, Xi Zhang, Keqian Du, Zhengquan Xie, Zhiming Lin
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis
Qian Shen, Rong Liu, Shiyu Tan, Xiaoding Xu, Junyue Fang, Rong Li
FRONTIERS IN IMMUNOLOGY (2022)
Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
Masataka Yokode, Masahiro Shiokawa, Yuzo Kodama
DIAGNOSTICS (2021)
Pterostilbene pre-treatment reduces LPS-induced acute lung injury through activating NR4A1
Ying Li, Shu-Min Wang, Xing Li, Chang-Jun Lv, Ling-Yun Peng, Xiao-Feng Yu, Ying-Jian Song, Cong-Jie Wang
PHARMACEUTICAL BIOLOGY (2022)
Epigenetic regulation of B cells and its role in autoimmune pathogenesis
Fan Xiao, Ke Rui, Xiaofei Shi, Haijing Wu, Xiaoyan Cai, Kathy O. Lui, Qianjin Lu, Esteban Ballestar, Jie Tian, Hejian Zou, Liwei Lu
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Aldose reductase deficiency inhibits LPS-induced M1 response in macrophages by activating autophagy
Peng Cheng, Jianwei Xie, Zhiyong Liu, Jian Wang
CELL AND BIOSCIENCE (2021)
TNFAIP3-upregulated RIP3 exacerbates acute pancreatitis via activating NLRP3 inflammasome
Yifan Wang, Menglong Song, Ping Zhou, Jiandong Wang, Jun Zheng, Haidong Xu
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
B cell-activating factor and its targeted therapy in autoimmune diseases
Yidan Zhang, Jie Tian, Fan Xiao, Leting Zheng, Xiaoxia Zhu, Ling Wu, Cheng Zhao, Shengjun Wang, Ke Rui, Hejian Zou, Liwei Lu
CYTOKINE & GROWTH FACTOR REVIEWS (2022)
Steroid treatment response combined with serological mark in differentiating type-1 autoimmune pancreatitis from pancreatic cancer
Bingqian Liu, Ning Tang, Yuan Yao, Hua Li, Lishan Xu, Bin Zhou, Bin Liu
MEDICINE (2022)
Intratumoral plasma cells More than a predictive marker of response to anti-PD-L1 treatment in lung cancer?
Jean-Lu Teillauo, Marie-Caroline Dieu-Nosjean
CANCER CELL (2022)
Anti-Mullerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS
Ewa Rudnicka, Michal Kunicki, Anna Calik-Ksepka, Katarzyna Suchta, Anna Duszewska, Katarzyna Smolarczyk, Roman Smolarczyk
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib
Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hiroshi Shibata, Tomoko Aoki, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Kouji Joko, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa, Masatoshi Kudo
CANCER MEDICINE (2023)
Development and validation of a modified albumin-bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Noritomo Shimada, Kazuhito Kawata, Hisashi Kosaka, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Takashi Kumada
HEPATOLOGY INTERNATIONAL (2023)
Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test
Atsushi Hiraoka, Masato Nakai, Nagisa Hara, Tatsunori Hanai, Tadashi Namisaki, Hisamitsu Miyaaki, Takashi Nakahara, Akira Hiramatsu, Hideko Ohama, Fujimasa Tada, Hirokazu Takahashi, Hiroshi Aikata, Yuichiro Eguchi, Yoichi Hiasa, Hitoshi Yoshiji
HEPATOLOGY RESEARCH (2023)
Spleen stiffness in patients with chronic liver disease evaluated by 2-D shear wave elastography with ultrasound multiparametric imaging
Masashi Hirooka, Yohei Koizumi, Yoshiko Nakamura, Ryo Yano, Yuki Okazaki, Koutarou Sunago, Yusuke Imai, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
HEPATOLOGY RESEARCH (2023)
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis
Takeshi Hatanaka, Atsushi Naganuma, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Noritomo Shimada, Kazuhito Kawata, Hisashi Kosaka, Satoru Kakizaki, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Takashi Kumada
CANCER MEDICINE (2023)
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non-viral infection: A Japanese multicenter observational study
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Noritomo Shimada, Kazuhito Kawata, Hisashi Kosaka, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Kouji Joko, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Takashi Kumada
CANCER MEDICINE (2023)
Development and validation of a modified albumin-bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab (September, 10.1007/s12072-022-10406-8, 2022)
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Noritomo Shimada, Kazuhito Kawata, Hisashi Kosaka, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Takashi Kumada
HEPATOLOGY INTERNATIONAL (2023)
Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow-up results of phase IIa clinical study
Osamu Yoshida, Sheikh Mohammad Fazle Akbar, Yusuke Imai, Takahiro Sanada, Kyoko Tsukiyama-Kohara, Takashi Miyazaki, Taizou Kamishita, Teruki Miyake, Yoshio Tokumoto, Hayato Hikita, Masataka Tsuge, Masahito Shimizu, Mamun Al Mahtab, Julio Cesar Aguilar, Gerardo Guillen, Michinori Kohara, Yoichi Hiasa
HEPATOLOGY RESEARCH (2023)
Significant association between HLA-B35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients
Ryosuke Nakamura, Noriaki Arakawa, Yoichi Tanaka, Nahoko Uchiyama, Akihiro Sekine, Yoichi Mashimo, Keiji Tsuji, Tatehiro Kagawa, Ken Sato, Masaaki Watanabe, Mitsuhiko Aiso, Yoichi Hiasa, Yoshiyuki Takei, Hiromasa Ohira, Minoru Ayada, Eri Tsukagoshi, Keiko Maekawa, Masahiro Tohkin, Yoshiro Saito, Hajime Takikawa
HEPATOLOGY RESEARCH (2023)
Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
Kozue Kanemitsu-Okada, Masanori Abe, Yoshiko Nakamura, Teruki Miyake, Takao Watanabe, Osamu Yoshida, Yohei Koizumi, Masashi Hirooka, Yoshio Tokumoto, Bunzo Matsuura, Mitsuhito Koizumi, Yoichi Hiasa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa
CANCER MEDICINE (2023)
Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients- multicenter analysis
Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Masaki Kaibori, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Kouji Joko, Hiroko Iijima, Hisashi Kosaka, Yoichi Hiasa, Masatoshi Kudo
LIVER CANCER (2023)
Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
Teru Kumagi, Takashi Terao, Taira Kuroda, Mitsuhito Koizumi, Yoshiki Imamura, Yoshinori Ohno, Tomoyuki Yokota, Nobuaki Azemoto, Kazuhiro Uesugi, Yoshiyasu Kisaka, Yoshinori Tanaka, Naozumi Shibata, Hideki Miyata, Teruki Miyake, Yoichi Hiasa
CANCERS (2023)
Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, Kanako Kato, Yoshiko Fukunishi, Emi Yanagihara, Masaya Kato, Hironobu Saneto, Hirofumi Izumoto, Hidetaro Ueki, Takeaki Yoshino, Shogo Kitahata, Tomoe Kawamura, Taira Kuroda, Yoshifumi Suga, Hideki Miyata, Jun Hanaoka, Jota Watanabe, Hiromi Ohtani, Masashi Hirooka, Masanori Abe, Bunzo Matsuura, Tomoyuki Ninomiya, Yoichi Hiasa
CANCERS (2023)
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
Margherita Rimini, Mara Persano, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, Jose Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Fabio Piscaglia, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Tiziana Pressiani, Margarida Montes, Caterina Vivaldi, Caterina Solda, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Valentina Burgio, Lorenza Rimassa, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
TARGETED ONCOLOGY (2023)